Literature DB >> 23853017

Anaphylactic shock and cardiac arrest caused by thiamine infusion.

Jacob Juel1, Manan Pareek, Christian Sigvald Langfrits, Svend Eggert Jensen.   

Abstract

Parenteral thiamine has a very high safety profile. The most common adverse effect is local irritation; however, anaphylactic or anaphylactoid reactions may occur, mostly related to intravenous administration. We describe a 44-year-old man, a chronic alcoholic, who was admitted with alcohol intoxication and developed cardiac arrest due to anaphylactic shock following intravenous thiamine infusion. The patient was successfully resuscitated after 15 min and repeated epinephrine administrations. He was discharged in good health after 14 days. This case report emphasises both the importance of recognising the symptoms of anaphylaxis and the fact that facilities for treating anaphylaxis and cardiopulmonary resuscitation should be available when thiamine or for that matter, any drug is given in-hospital.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23853017      PMCID: PMC3736362          DOI: 10.1136/bcr-2013-009648

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  Anaphylaxis from intravenous thiamine--long forgotten?

Authors:  S Johri; S Shetty; A Soni; S Kumar
Journal:  Am J Emerg Med       Date:  2000-09       Impact factor: 2.469

Review 2.  Anaphylaxis: mechanisms and management.

Authors:  J K Lee; P Vadas
Journal:  Clin Exp Allergy       Date:  2011-07       Impact factor: 5.018

Review 3.  Pathophysiology of anaphylaxis.

Authors:  Bilal Q Khan; Stephen F Kemp
Journal:  Curr Opin Allergy Clin Immunol       Date:  2011-08

4.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis.

Authors:  L B Schwartz; J W Yunginger; J Miller; R Bokhari; D Dull
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

Review 5.  Thiamine-induced anaphylactic shock.

Authors:  P Van Haecke; D Ramaekers; L Vanderwegen; S Boonen
Journal:  Am J Emerg Med       Date:  1995-05       Impact factor: 2.469

Review 6.  Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management.

Authors:  Gianpietro Sechi; Alessandro Serra
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

Review 7.  Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization.

Authors:  S F Kemp; R F Lockey; F E R Simons
Journal:  Allergy       Date:  2008-08       Impact factor: 13.146

8.  2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis.

Authors:  F Estelle R Simons; Ledit R F Ardusso; M Beatrice Bilò; Vesselin Dimov; Motohiro Ebisawa; Yehia M El-Gamal; Dennis K Ledford; Richard F Lockey; Johannes Ring; Mario Sanchez-Borges; Gian Enrico Senna; Aziz Sheikh; Bernard Y Thong; Margitta Worm
Journal:  Curr Opin Allergy Clin Immunol       Date:  2012-08

9.  Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis.

Authors:  L B Schwartz; D D Metcalfe; J S Miller; H Earl; T Sullivan
Journal:  N Engl J Med       Date:  1987-06-25       Impact factor: 91.245

10.  A toxicity study of parenteral thiamine hydrochloride.

Authors:  K D Wrenn; F Murphy; C M Slovis
Journal:  Ann Emerg Med       Date:  1989-08       Impact factor: 5.721

View more
  2 in total

1.  Vitamin and Mineral Deficiencies After Biliopancreatic Diversion and Biliopancreatic Diversion with Duodenal Switch--the Rule Rather than the Exception.

Authors:  Jens Homan; Bark Betzel; Edo O Aarts; K Dogan; Kees J H M van Laarhoven; Ignace M C Janssen; Frits J Berends
Journal:  Obes Surg       Date:  2015-09       Impact factor: 4.129

Review 2.  Insights Into Thiamine Supplementation in Patients With Septic Shock.

Authors:  Nara Aline Costa; Amanda Gomes Pereira; Clara Sandra Araujo Sugizaki; Nayane Maria Vieira; Leonardo Rufino Garcia; Sérgio Alberto Rupp de Paiva; Leonardo Antonio Mamede Zornoff; Paula Schmidt Azevedo; Bertha Furlan Polegato; Marcos Ferreira Minicucci
Journal:  Front Med (Lausanne)       Date:  2022-01-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.